[HTML][HTML] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

MA Pfeffer, JJV McMurray, EJ Velazquez… - … England Journal of …, 2003 - Mass Medical Soc
Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …

[引用][C] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

P MA - N Engl J Med, 2003 - cir.nii.ac.jp
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left
ventricular dysfunction, or both | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[PDF][PDF] Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau… - N Engl J Med, 2003 - puppem.com
Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce mortality and
cardiovascular morbidity among patients with myocardial infarction complicated by left …

[PDF][PDF] Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

MA Pfeffer, JJV McMurray, EJ Velazquez… - N Engl J …, 2003 - researchgate.net
Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce mortality and
cardiovascular morbidity among patients with myocardial infarction complicated by left …

[引用][C] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

MA Pfeffer, JJV McMurray, EJ Velazquez… - New England Journal …, 2003 - repositorio.usp.br
ReP USP - Detalhe do registro: Valsartan, captopril, or both in myocardial infarction
complicated by heart failure, left ventricular dysfunction, or both Home About USP Schools …

[引用][C] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

MA PFEFFER, JJV MCMURRAY… - The New England …, 2003 - pascal-francis.inist.fr
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left
ventricular dysfunction, or both CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[PDF][PDF] Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau… - N Engl J Med, 2003 - puppem.com
Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce mortality and
cardiovascular morbidity among patients with myocardial infarction complicated by left …

[DOC][DOC] Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

MA Pfeffer - medsol.co
Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

LS Piegas - N Engl J Med, 2003 - pesquisa.bvsalud.org
Angiotensin-converting enzyme (ACE) inhibitors such as captopril reduce mortality and
cardiovascular morbidity among patients with myocardial infarction complicated by left …

[PDF][PDF] Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau… - N Engl J Med, 2003 - Citeseer
Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce mortality and
cardiovascular morbidity among patients with myocardial infarction complicated by left …